October 2018 FDA Recall Omnipaque by Ge Healthcare Inc. Life Sciences
D-0319-2019 - Defective Container

This Class II drug recall was voluntarily initiated by Ge Healthcare Inc. Life Sciences on October 29, 2018 for the product Omnipaque. The FDA reported the reason for recall as defective container. The product was distributed in TN and the recall is currently terminated.

Recall Number: D-0319-2019

Reason for Recall
Defective Container: vial defect was identified that could potentially impact the container closure and result in a lack of sterility assurance and/or the potential for glass particles.
Initiated
10-29-2018
Reported
12-26-2018
Quantity
1092 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
GE Healthcare Inc. Life Sciences
Omnipaque (iohexol) Injection, 180mgI/mL, 20 mL Single-Dose Vial, packaged in 10 x 20 mL Vials per carton, Rx only, Distributed by GE Healthcare Inc., Marlborough, MA 01752 U.S.A.; Manufactured by GE Healthcare AS, Oslo, Norway; NDC 0407-1411-20.

Batch or Lot Expiration Information

Lot# : 14301544, Exp 21Sep21